El interés en corto de AirSculpt Technologies da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de AirSculpt Technologies. Los datos de interés en corto se actualizan cada dos semanas.

AirSculpt Technologies (NASDAQ:AIRS) Bolsa, Informe de interés en corto

AirSculpt Technologies

AirSculpt Technologies Inc is a national provider of body contouring procedures delivering a premium consumer experience under its brand Elite Body Sculpture. At Elite Body Sculpture, company provide custom body contouring using proprietary AirSculpt method that removes unwanted fat in a minimally invasive procedure.

AirSculpt Technologies, Inc. - Common Stock

AirSculpt Technologies Inc

AirSwap - United States Dollar

Airship AI Holdings, Inc - Class A Common Stock

Airship AI Holdings Inc

Airspan Networks Holdings Inc

Airspan Networks Holdings Inc Warrants (01/11/2026)

Airspan Networks Holdings Inc Warrants - Class C (01/11/2026)

-Reuters, citing conference presentation

Health Care

General

GILD

Gilead Exec Says Co Expects To Do "Something Like A Cymabay Acquisition Every Couple Of Years

A United Airlines Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) analyst says the company could mirror recent earnings strength and guidance that Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>) had when the company reports fourth-quarter financial results <a href="https://www.benzinga.com/earnings">on Jan. 21.</a>
The United Airlines Analyst: Bank of America analyst Andrew Didora reiterated a Buy rating on United Airlines and raised the price target from $100 to $120.
The Analyst Takeaways: United Airlines could be the biggest winner from a strong outlook<a href="https://www.benzinga.com/25/01/42912208/delta-stock-jumps-after-record-q4-earnings-and-strong-2025-outlook"> shared by Delta, </a>Didora said in a new investor note.
"We expect UAL to report strong 4Q24 results and guide 1Q25 ahead of consensus when the company reports earnings on 1/21," Didora said.
The analyst raised fourth quarter, first quarter and full year 2025 earnings per share estimates ahead of the earnings report.
"The airline is the biggest beneficiary of the strong premium, corporate, and transatlantic growth mentioned in DAL's earnings report last week."
Didora said United's premium product offering and coastal hubs that see strong corporate share should see the airline company reporting results in line with Delta or better.
"The magnitude of DAL's +7-9% 1Q25 revenue guide was a positive surprise to us, and this outlook was well ahead of our prior/Visible Alpha consensus 1Q25 revenue growth forecast of +6.0% for UAL."
The analyst estimates UAL could see 7.5% year-over-year growth in the first quarter based on Delta's report.
"We are modeling consistent unit revenue growth throughout 2025 of around 3% for total revenue growth of +7.6%."
The analyst said the new forecast should allow United to see both higher earnings and free cash flow, allowing the company to complete its buyback and see "further de-leveraging."
UAL Price Action: United Airlines stock is down 3.32% to $103.52 at publication Monday versus a 52-week trading range of $37.02 to $110.92. United Airlines stock is up 164% over the last year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/travel/24/12/42450095/us-airlines-set-to-fly-high-in-2025-analyst-says-perfect-storm-of-tailwinds-will-propel-industry-gains">US Airlines Set To Fly High In 2025, Analyst Says: &#8216;Perfect Storm Of Tailwinds&#8217; Will Propel Industry Gains</a></li>
</ul>
Photo: Shutterstock

Analyst Color

Price Target

Previews

Reiteration

Travel

Analyst Ratings

Trading Ideas

United Airlines Earnings Preview: Could Airline Impress Investors After Delta's Strong Guidance?

Whales with a lot of money to spend have taken a noticeably bearish stance on Riot Platforms.
Looking at options history for Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) we detected 21 trades.
If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened trades with bullish expectations and 42% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $96,145 and 18, calls, for a total amount of $1,300,893.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $8.0 and $20.0 for Riot Platforms, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Riot Platforms options trades today is 19933.44 with a total volume of 90,039.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Riot Platforms's big money trades within a strike price range of $8.0 to $20.0 over the last 30 days.
<h3>Riot Platforms 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736797543_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.45</td>
<td>$1.43</td>
<td>$1.44</td>
<td>$14.00</td>
<td>$247.1K</td>
<td>32.9K</td>
<td>43.7K</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.45</td>
<td>$1.37</td>
<td>$1.37</td>
<td>$14.00</td>
<td>$201.2K</td>
<td>32.9K</td>
<td>2.4K</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$1.42</td>
<td>$1.37</td>
<td>$1.42</td>
<td>$14.00</td>
<td>$142.1K</td>
<td>32.9K</td>
<td>3.1K</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$3.35</td>
<td>$3.25</td>
<td>$3.3</td>
<td>$17.00</td>
<td>$133.6K</td>
<td>6.5K</td>
<td>494</td>
</tr>
<tr>
<td>RIOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.3</td>
<td>$4.25</td>
<td>$4.25</td>
<td>$12.00</td>
<td>$80.7K</td>
<td>7.2K</td>
<td>884</td>
</tr>
</tbody>
</table>

<h3>About Riot Platforms</h3>
Riot Platforms Inc is a vertically integrated Bitcoin mining company focused on building, supporting, and operating blockchain technologies. The company's segments include Bitcoin Mining; Data Center Hosting and Engineering. It generates maximum revenue from the Bitcoin Mining segment which generates revenue from the Bitcoin the company earns through its mining activities.
Having examined the options trading patterns of Riot Platforms, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Riot Platforms Standing Right Now?</h3>
<ul>
<li>With a trading volume of 16,240,684, the price of RIOT is down by -5.5%, reaching $11.34.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 38 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Riot Platforms</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $23.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Overweight, adjusting the price target to $23. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Riot Platforms, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

RIOT

Riot Platforms's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bearish stance on Amgen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with AMGN, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 11 options trades for Amgen.
This isn't normal.
The overall sentiment of these big-money traders is split between 27% bullish and 63%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $306,375, and 10, calls, for a total amount of $382,064.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $220.0 to $300.0 for Amgen during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Amgen options trades today is 1857.57 with a total volume of 1,376.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Amgen's big money trades within a strike price range of $220.0 to $300.0 over the last 30 days.
<h3>Amgen Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736797538_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$14.25</td>
<td>$14.2</td>
<td>$14.25</td>
<td>$260.00</td>
<td>$306.3K</td>
<td align="right">231</td>
<td align="right">109</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$46.0</td>
<td>$44.15</td>
<td>$46.0</td>
<td>$220.00</td>
<td>$73.6K</td>
<td align="right">239</td>
<td align="right">9</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$14.7</td>
<td>$14.35</td>
<td>$14.7</td>
<td>$290.00</td>
<td>$63.2K</td>
<td align="right">60</td>
<td align="right">43</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$3.3</td>
<td>$3.15</td>
<td>$3.3</td>
<td>$300.00</td>
<td>$40.9K</td>
<td align="right">493</td>
<td align="right">129</td>
</tr>
<tr>
<td>AMGN</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.25</td>
<td>$9.85</td>
<td>$9.85</td>
<td>$290.00</td>
<td>$35.4K</td>
<td align="right">158</td>
<td align="right">94</td>
</tr>
</tbody>
</table>

<h3>About Amgen</h3>
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.
Having examined the options trading patterns of Amgen, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Amgen</h3>
<ul>
<li>With a trading volume of 1,552,050, the price of AMGN is down by -0.1%, reaching $261.96.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 22 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Amgen</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $296.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Wells Fargo continues to hold a Equal-Weight rating for Amgen, targeting a price of $280. 
&#x2A; Consistent in their evaluation, an analyst from Truist Securities keeps a Hold rating on Amgen with a target price of $298. 
&#x2A; An analyst from Piper Sandler persists with their Overweight rating on Amgen, maintaining a target price of $310. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Amgen with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

AMGN

Unpacking the Latest Options Trading Trends in Amgen

Financial giants have made a conspicuous bearish move on Qualcomm. Our analysis of options history for Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) revealed 31 unusual trades.
Delving into the details, we found 29% of traders were bullish, while 45% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $951,965, and 17 were calls, valued at $1,247,474.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $105.0 to $170.0 for Qualcomm during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Qualcomm's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Qualcomm's whale trades within a strike price range from $105.0 to $170.0 in the last 30 days. 
<h3>Qualcomm Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736797533_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$7.8</td>
<td>$7.7</td>
<td>$7.7</td>
<td>$140.00</td>
<td>$295.6K</td>
<td>1.8K</td>
<td align="right">384</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.7</td>
<td>$3.55</td>
<td>$3.65</td>
<td>$105.00</td>
<td>$164.2K</td>
<td>2.8K</td>
<td align="right">472</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$27.3</td>
<td>$27.2</td>
<td>$27.2</td>
<td>$150.00</td>
<td>$147.0K</td>
<td>1.4K</td>
<td align="right">130</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$32.95</td>
<td>$31.8</td>
<td>$31.8</td>
<td>$135.00</td>
<td>$146.2K</td>
<td>33</td>
<td align="right">0</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$38.85</td>
<td>$38.6</td>
<td>$38.6</td>
<td>$130.00</td>
<td>$131.2K</td>
<td>677</td>
<td align="right">62</td>
</tr>
</tbody>
</table>

<h3>About Qualcomm</h3>
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
After a thorough review of the options trading surrounding Qualcomm, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Current Position of Qualcomm</h3>
<ul>
<li>Trading volume stands at 2,864,603, with QCOM's price down by -0.13%, positioned at $156.78.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 16 days.</li>
</ul>
<h3>Professional Analyst Ratings for Qualcomm</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $215.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Qualcomm with a target price of $215. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Qualcomm, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

QCOM

Behind the Scenes of Qualcomm's Latest Options Trends

Donald Trump's economic planning is often referred to as "Maganomics," a phrase based on his campaign slogan, "Make <a href="https://www.benzinga.com/topic/donald-trump">America Great Again.&#8221; </a> Trump&#8217;s policy ideas have led to divided opinions between economists and investors, according to a <a href="https://www.ft.com/content/cbdcf6f1-16d5-4ce9-aa94-5d3098cc19b8">report </a>by the Financial Times. The former worry about the potential shortcomings of protectionist policies such as tariffs and immigration curbs, while investors are focusing on the brighter side, especially for U.S. manufacturing. And here's where things get interesting— certain ETFs might gain from these dynamics.
See Also: <a href="https://www.benzinga.com/25/01/42948649/goldman-sachs-warns-of-90-oil-risk-trump-may-not-ease-sanctions-once-he-takes-office">Oil Could Hit $90, Goldman Sachs Says: &#8216;Trump May Not Ease Sanctions&#8217; On Russia</a>
Trump's targeted tariffs and pro-business standpoint is designed to increase domestic manufacturing and attract investment into sectors like industrials and materials. The idea is simple: by imposing tariffs on imports, U.S.-made goods become more competitive and encourage domestic manufacturers to up their production. For investors, this shift can push economic growth, despite warnings from experts.
This optimism among investors makes ETFs heavy on manufacturing and industrial growth particularly appealing. Funds like the iShares U.S. Industrials ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IYJ#BATS">IYJ</a>) or the SPDR S&amp;P Metals and Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XME#NYSE">XME</a>) could gain directly from increased investment in American factories and infrastructure. These ETFs provide exposure to companies that are likely to thrive under policies encouraging domestic production.
The iShares U.S. Industrials ETF has an expense ratio of 0.39% and includes some big names in the industrials sector, like GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), Honeywell International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HON#NYSE">HON</a>) and Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>) in its holdings.
Meanwhile, the SPDR S&amp;P Metals and Mining ETF, with an even lower expense ratio of 0.35%, is exposed to the steel industry by 51.04%, coal and consumable fuels by 13.31%, aluminum by 7.18% and diversified metal and mining by 5.58%, among others.
An analyst at T. Rowe Price, cited by the Financial Times, suggests that Trump&#8217;s pro-business policies could encourage companies previously hesitant under past administrations to boost their spending.
This could also help funds like the Vanguard Industrials ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIS#NYSE">VIS</a>), which invests in a broader range of industrial sectors.
Ultimately, the appeal of "Maganomics" for investors lies in how likely it is to create short-term winners, especially in manufacturing and industrials. ETFs that play with these themes could allow investors to ride the wave of optimism while diversifying risk.
See Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42925809/semiconductor-etf-faces-key-resistance-in-ai-driven-surge-analyst">Semiconductor ETF Faces Key Resistance In AI-Driven Surge: Analyst</a></li>
</ul>
Image created using photos from Shutterstock.

Sector ETFs

Politics

ETFs

iShares Trust Dow Jones US Industrial Sector Index Fund

How Trump's 'Maganomics' Could Power Industrials-Focused ETFs

Macro Economic Events

Economics

Hamas Delegation In Doha Says Gaza Ceasefire Talks Progressing Well With Group Dealing With Developments In Positive Manner

Deep-pocketed investors have adopted a bearish approach towards Hut 8 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in HUT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 11 extraordinary options activities for Hut 8. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 36% leaning bullish and 63% bearish. Among these notable options, 3 are puts, totaling $253,958, and 8 are calls, amounting to $305,176.
<h3>Expected Price Movements</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $20.0 to $37.0 for Hut 8 over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Hut 8's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Hut 8's substantial trades, within a strike price spectrum from $20.0 to $37.0 over the preceding 30 days.
<h3>Hut 8 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736796634_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HUT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.55</td>
<td>$9.25</td>
<td>$9.55</td>
<td>$25.00</td>
<td>$191.0K</td>
<td align="right">138</td>
<td align="right">200</td>
</tr>
<tr>
<td>HUT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$2.09</td>
<td>$1.75</td>
<td>$1.97</td>
<td>$25.00</td>
<td>$62.0K</td>
<td align="right">323</td>
<td align="right">536</td>
</tr>
<tr>
<td>HUT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.0</td>
<td>$0.91</td>
<td>$1.0</td>
<td>$23.00</td>
<td>$52.2K</td>
<td align="right">240</td>
<td align="right">928</td>
</tr>
<tr>
<td>HUT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.0</td>
<td>$0.91</td>
<td>$0.98</td>
<td>$23.00</td>
<td>$36.9K</td>
<td align="right">240</td>
<td align="right">406</td>
</tr>
<tr>
<td>HUT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$1.98</td>
<td>$1.95</td>
<td>$1.95</td>
<td>$25.00</td>
<td>$36.0K</td>
<td align="right">323</td>
<td align="right">221</td>
</tr>
</tbody>
</table>

<h3>About Hut 8</h3>
Hut 8 Corp is engaged in the mining of digital assets with an operational focus on utilizing specialized equipment to solve complex computational problems to validate transactions on the Bitcoin blockchain and receiving Bitcoin in return for successful services. The company has four reportable business segments: Digital Assets Mining, Managed Services, High Performance Computing -Colocation and Cloud, and Other. It derives maximum revenue from Digital Assets Mining segment.
<h3>Where Is Hut 8 Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,729,527, with HUT's price down by -3.89%, positioned at $22.49.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 73 days.</li>
</ul>
<h3>What The Experts Say On Hut 8</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $37.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Needham keeps a Buy rating on Hut 8 with a target price of $38. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $38. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $35. 
&#x2A; Reflecting concerns, an analyst from Benchmark lowers its rating to Buy with a new price target of $41. 
&#x2A; In a cautious move, an analyst from Piper Sandler downgraded its rating to Overweight, setting a price target of $33. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Hut 8 options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Decoding Hut 8's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bullish approach towards CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CRWD usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 108 extraordinary options activities for CrowdStrike Holdings. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 40% bearish. Among these notable options, 36 are puts, totaling $3,653,540, and 72 are calls, amounting to $4,061,788.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $170.0 to $540.0 for CrowdStrike Holdings over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for CrowdStrike Holdings's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CrowdStrike Holdings's whale trades within a strike price range from $170.0 to $540.0 in the last 30 days. 
<h3>CrowdStrike Holdings Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736796629_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$28.0</td>
<td>$26.65</td>
<td>$27.25</td>
<td>$280.00</td>
<td>$654.0K</td>
<td>583</td>
<td align="right">241</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/18/26</td>
<td>$26.55</td>
<td>$25.75</td>
<td>$25.95</td>
<td>$240.00</td>
<td>$371.0K</td>
<td>109</td>
<td align="right">143</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$21.45</td>
<td>$21.0</td>
<td>$21.4</td>
<td>$300.00</td>
<td>$214.0K</td>
<td>1.2K</td>
<td align="right">108</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$105.75</td>
<td>$104.9</td>
<td>$104.9</td>
<td>$420.00</td>
<td>$209.9K</td>
<td>106</td>
<td align="right">180</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$183.9</td>
<td>$180.15</td>
<td>$181.86</td>
<td>$185.00</td>
<td>$200.0K</td>
<td>12</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About CrowdStrike Holdings</h3>
CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.
After a thorough review of the options trading surrounding CrowdStrike Holdings, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>CrowdStrike Holdings's Current Market Status</h3>
<ul>
<li>Trading volume stands at 1,944,632, with CRWD's price down by -3.64%, positioned at $336.13.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 50 days.</li>
</ul>
<h3>What Analysts Are Saying About CrowdStrike Holdings</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $420.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on CrowdStrike Holdings with a target price of $450. 
&#x2A; An analyst from Goldman Sachs persists with their Buy rating on CrowdStrike Holdings, maintaining a target price of $415. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on CrowdStrike Holdings, which currently sits at a price target of $400. 
&#x2A; An analyst from JP Morgan has decided to maintain their Overweight rating on CrowdStrike Holdings, which currently sits at a price target of $418. 
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on CrowdStrike Holdings, which currently sits at a price target of $420. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for CrowdStrike Holdings, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

CRWD

Decoding CrowdStrike Holdings's Options Activity: What's the Big Picture?

Deep-pocketed investors have adopted a bullish approach towards Northrop Grumman (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOC#NYSE">NOC</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in NOC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Northrop Grumman. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 4 are puts, totaling $141,980, and 5 are calls, amounting to $341,020.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $450.0 to $500.0 for Northrop Grumman over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In terms of liquidity and interest, the mean open interest for Northrop Grumman options trades today is 125.88 with a total volume of 108.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Northrop Grumman's big money trades within a strike price range of $450.0 to $500.0 over the last 30 days.
<h3>Northrop Grumman Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736796624_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOC</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$34.5</td>
<td>$31.3</td>
<td>$33.0</td>
<td>$450.00</td>
<td>$99.0K</td>
<td align="right">30</td>
<td align="right">30</td>
</tr>
<tr>
<td>NOC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$31.2</td>
<td>$28.1</td>
<td>$30.8</td>
<td>$450.00</td>
<td>$92.4K</td>
<td align="right">96</td>
<td align="right">30</td>
</tr>
<tr>
<td>NOC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$19.6</td>
<td>$19.1</td>
<td>$19.6</td>
<td>$490.00</td>
<td>$74.4K</td>
<td align="right">6</td>
<td align="right">40</td>
</tr>
<tr>
<td>NOC</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$38.0</td>
<td>$38.0</td>
<td>$38.0</td>
<td>$500.00</td>
<td>$49.4K</td>
<td align="right">59</td>
<td align="right">13</td>
</tr>
<tr>
<td>NOC</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$48.1</td>
<td>$44.7</td>
<td>$45.6</td>
<td>$490.00</td>
<td>$45.6K</td>
<td align="right">67</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About Northrop Grumman</h3>
Northrop Grumman is a diversified defense contractor providing aeronautics, defense, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces autonomous and piloted aircraft such as Global Hawk drones and the new B-21 bomber. Defense systems makes artillery and missile ammunition and guidance systems, missile defense systems, and maintains and upgrades numerous military aircraft. Mission systems creates and integrates a variety of radar, navigation, and communication systems for avionics, weapons control, and countermeasures on a range of platforms from helicopters to destroyers. Space systems produces satellites, sensors, space structures, and manufactures long-range missiles and rocket motors.
Following our analysis of the options activities associated with Northrop Grumman, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Northrop Grumman</h3>
<ul>
<li>Currently trading with a volume of 520,160, the NOC's price is up by 3.49%, now at $474.71. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 17 days.</li>
</ul>
<h3>Professional Analyst Ratings for Northrop Grumman</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $528.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Susquehanna persists with their Positive rating on Northrop Grumman, maintaining a target price of $557. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Equal-Weight rating on Northrop Grumman with a target price of $500. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Northrop Grumman options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

Northrop Grumman's Options Frenzy: What You Need to Know

Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Equal-Weight and lowers the price target from $42 to $40.

News

RXST

Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $40

Needham analyst N. Quinn Bolton maintained ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Buy and lowered the <a href="https://www.benzinga.com/quote/ON/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $87 to $66</a>.
Bolton met with ON Semiconductor management at the annual Consumer Electronics Show last week.
Like recent quarters, end demand conditions remain muted across the company&#8217;s key industrial and automotive end markets, and inventory digestion continues.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42881735/verizon-hits-55-gbps-5g-speeds-lands-air-force-deal-to-upgrade-base-networks-nationwide" rel="noreferrer noopener">Verizon Hits 5.5 Gbps 5G Speeds, Lands Air Force Deal to Upgrade Base Networks Nationwide</a>
In the near term, turn orders have been weaker than expected, and management expects results to be below typical seasonal patterns for the first half of 2025.
Reflecting the weak demand conditions, Bolton expects management to further reduce fab utilization rates below the 65% level at which utilization ran for most of 2024.
The lower fab utilization rates will likely push adjusted gross margin below 45% in the first half of 2025.
While Bolton continues to view ON Semiconductor as a promising semiconductor cycle recovery play, the delayed industry recovery prompted Bolton to reduce his forward estimates and lower the price target.
Inventory digestion continues to be pushed out; demand remains soft. Like the last earnings call, softness has continued in the market over the past several months.
The demand environment remains muted with ongoing inventory digestion and slow end-market demand.
Further, ON Semiconductor&#8217;s turns business has slowed significantly over the last 30-40 days, and visibility is a quarter at best. Slowing EV sell-through is weighing on auto demand.
Industrial has yet to broadly recover except for pockets of strength in utility-scale solar and A&amp;D.
Regionally, China and Japan are recovering with strength in BEVs, but North America and the European Union remain soft in both automotive and industrial.
Management expects revenue to be &#8220;sub-seasonal&#8221; for the next couple of quarters and is not planning for an industry recovery in 2025.
Slowing turns business is leading to lower utilization.
Management noted it plans to lower utilization rates in the near term (~65% last quarter), contrary to the last earnings call, when it planned to keep utilization flat, driven by the increased weakness in the turn business seen in the last 30-40 days.
Management noted that if utilization ticks below 65%, the margin will likely sink below 45%.
However, once demand picks back up and utilization ramps back up, management believes it can quickly turn back on utilization and see a gross margin benefit.
Full utilization is around 83%- 85%. Each point of utilization equates to ~ a 15-20bps impact on gross margin. It expects superior tech will win in China regardless of government suggestions.
Management was clear that Chinese EV companies continue to use the company&#8217;s technology, and ON Semiconductor is winning a share within SiC despite the government&#8217;s recommendation to use domestic chips.
Management noted there is no viable local supplier of SiC devices and that Chinese EV companies continue to choose ON Semiconductor due to the best performance despite the fact that the devices and a majority of the SiC substrates are manufactured in the U.S.
Bolton projected fourth-quarter revenue of $1.72 billion (prior $1.76 billion) and adjusted EPS of $0.93 (prior $0.98).
Price Action: ON stock is up 3.13% at $55.63 at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/42874446/samsungs-outlook-dims-amid-hbm-supply-struggles-for-nvidia-and-sluggish-consumer-chip-sales" target="_blank" rel="noreferrer noopener">Samsung&#8217;s Outlook Dims Amid HBM Supply Struggles for Nvidia and Sluggish Consumer Chip Sales</a></li>
</ul>
Photo: Shutterstock

Asia

Tech

ON Semi Sees Utilization Cuts As EV Demand Softens, Analyst Warns

Wells Fargo analyst Neil Kalton upgrades Xcel Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XEL#NASDAQ">XEL</a>) from Equal-Weight to Overweight and raises the price target from $70 to $72.

Upgrades

Wells Fargo Upgrades Xcel Energy to Overweight, Raises Price Target to $72

Vera Therapeutics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares are trading lower by 7.3% to $34.31 Monday afternoon. The company announced an <a href="https://www.benzinga.com/pressreleases/25/01/g42940821/vera-therapeutics-acquires-global-rights-to-novel-next-generation-dual-baffapril-inhibitor">exclusive license agreement</a> with Stanford University for VT-109.
What To Know: Vera Therapeutics has secured an exclusive license from Stanford University for VT-109, a next-generation fusion protein targeting BAFF and APRIL. VT-109 offers broad therapeutic potential for B cell-mediated diseases, reinforcing Vera&#8217;s position in B cell modulation.
CEO Marshall Fordyce highlighted the company&#8217;s commitment to leveraging its expertise to advance the molecule&#8217;s potential and improve outcomes for patients with severe autoimmune diseases. 
Under the agreement, Vera gains development and marketing rights for VT-109 in exchange for undisclosed upfront and milestone payments.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42953940/tuesdays-producer-inflation-report-could-stoke-market-volatility-as-fed-path-remains-unclear">Tuesday&#8217;s Producer Inflation Report Could Stoke Market Volatility As Fed Path Remains Unclear</a>
<h2 class="wp-block-heading">How To Buy VERA Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Vera Therapeutics&#8217;s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, VERA has a 52-week high of $51.61 and a 52-week low of $14.20.

VERA

What's Going On With Vera Therapeutics Stock?

William Blair analyst Bhavan Suri downgrades Enfusion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENFN#NYSE">ENFN</a>) from Outperform to Market Perform.

Downgrades

ENFN

William Blair Downgrades Enfusion to Market Perform

Traders adopted a cautious approach on Monday as they awaited two critical inflation reports due later this week, seeking clarity on Federal <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42953940/tuesdays-producer-inflation-report-could-stoke-market-volatility-as-fed-path-remains-unclear">Reserve interest rate policy. </a>
Additionally, the kickoff of earnings season, led by major banks on Wednesday, added to <a href="https://www.benzinga.com/markets">the market&#8217;s subdued tone.</a>
The S&amp;P 500 and Nasdaq 100 edged lower, continuing Friday&#8217;s downturn sparked by unexpectedly strong jobs data. The lack of &#8220;buy-the-dip&#8221; enthusiasm in the tech-heavy indices signaled lingering uncertainty among investors.
In contrast, the Dow Jones Industrial Average eked out a gain, buoyed by a rally in energy stocks. Rising oil prices provided a key lift, as West Texas Intermediate (WTI) crude oil surged over 3% to approach $78 per barrel — a level last seen in mid-August 2024. The spike followed U.S. sanctions on Russian crude exports announced on Friday, which shifted market expectations around supply and demand.
Treasury yields extended their ascent, with the 10-year yield climbing to 4.79% and the 30-year yield rising to 4.97%, reflecting heightened expectations for tighter monetary policy. Bank of America Securities launched a bombshell indicating rising risks towards a rate hike as the next Fed move.
Commodity markets saw mixed action. Gold endured its sharpest daily loss in nearly a month, falling more than 1% as rising yields weighed on the precious metal. Meanwhile, copper staged a modest rebound, gaining 0.8% after a 0.5% decline last Friday.
Cryptocurrencies faced renewed volatility, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) plunging 3% to dip below $92,000, briefly touching a two-month low. The ripple effects extended to crypto-linked equities: MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) slid more than 3%, while Coinbase Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) dropped nearly 4%.
<h1 class="wp-block-heading">Monday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day chg. %</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,144.04</td>
<td>0.5%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,822.92</td>
<td>-0.1%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,183.39</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,739.92</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 1:30 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent010625&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) inched 0.1% lower to $579.98.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;rose 0.7% to $422.03.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.6% to $504.44.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) dipped 0.3% to $216.19.</li>
<li>The&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 2.3%; the&nbsp;Technology Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Monday&#8217;s Stock Movers</h3>
<ul>
<li>Major oil &amp; gas giants rallying on Monday include Valero Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>), up 5%, Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>) up 3.9%, and Marathon Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) up 3.5%.</li>
<li>Health insurance companies surged after a government proposal suggested increased payments for Medicare Advantage plans in 2026, lifting sentiment across the sector.</li>
<li>Shares of Humana Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) rose 7.8%, CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>) followed closely with a 6.9% jump, while UnitedHealth Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) saw a 4.8% increase.+</li>
<li>NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) dropped 2.7% to $132.19 as the AI chipmaker urged President-elect Donald Trump to oppose Biden administration regulations on AI technology. Meanwhile, HSBC cut its price target from $195 to $185 but reaffirmed its Buy rating.</li>
<li>Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) plummeted 20% after projecting 2025 revenue of $1.5 billion to $2.5 billion, missing analysts&#8217; estimates of $2.92 billion. The company also announced it would fast-track its cost-cutting measures.</li>
<li>Edison International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIX#NYSE">EIX</a>) fell 12% as authorities investigated whether equipment from its subsidiary, Southern California Edison, played a role in sparking the Hurst fire in Los Angeles.</li>
</ul>
Read Now: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42948649/goldman-sachs-warns-of-90-oil-risk-trump-may-not-ease-sanctions-once-he-takes-office">Oil Could Hit $90, Goldman Sachs Says: &#8216;Trump May Not Ease Sanctions&#8217; On Russia</a></li>
</ul>
Photo: Ryan DeBerardinis via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Broad U.S. Equity ETFs

Commodities

Econ #s

Federal Reserve

$BTC

COIN

SPDR Dow Jones Industrial Average ETF Trust

MRNA

MSTR

NVDA

Stocks Edge Down Ahead Of Key Inflation Reports, Crude Hits 5-Month High, Bitcoin Sinks: What's Driving Markets Monday?

DatChat Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DATS#NASDAQ">DATS</a>) shares climbed 13.9% to $5.50 on Monday, recovering some losses after <a href="https://www.benzinga.com/news/25/01/42877960/why-datchat-dats-stock-is-getting-hammered">last week's pullback</a>. Monday&#8217;s rally occurred despite no new company-specific updates.
What To Know: Last Wednesday, DatChat shares plunged 64% to $3.22 after announcing a <a href="https://www.benzinga.com/pressreleases/25/01/g42873083/datchat-inc-announces-pricing-of-5-1-million-registered-direct-offering-priced-at-the-market-under">$5.1 million registered direct offering</a> priced at-the-market under Nasdaq rules. 
The company said plans to sell 1.2 million shares at $4.25 per share, with Benchmark Company, LLC acting as the sole placement agent. The offering aims to fund working capital and general corporate purposes.
Investors reacted sharply to the announcement, concerned about potential dilution. Monday's surge reflects renewed interest possibly driven by speculative activity.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42953757/whats-going-on-with-trump-media-technology-group-stock-4">What&#8217;s Going On With Trump Media &amp; Technology Group Stock?</a>
<h2 class="wp-block-heading">How To Buy DATS Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in DatChat&#8217;s case, it is in the Information Technology sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, DATS has a 52-week high of $9.34 and a 52-week low of $1.01.

DATS

DatChat (DATS) Stock Jumps After Last Week's Plunge: What's Going On?

UBS analyst Ashwani Verma maintains Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and lowers the price target from $22 to $14.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

UBS Maintains Buy on Avadel Pharmaceuticals, Lowers Price Target to $14

CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), Humana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) and UnitedHealth Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NYSE">UNH</a>) stock is moving higher on Monday. Here&#8217;s what you <a href="https://www.benzinga.com//node/42953047">need to know</a>.
What To Know: Shares of health insurance companies are trading higher after The Centers for Medicare and Medicaid Services proposed a rise to Medicare Advantage payments.
According to <a href="https://www.bloomberg.com/news/articles/2025-01-10/us-proposes-21-billion-boost-to-insurers-for-medicare-payments?embedded-checkout=true">Bloomberg</a>, the proposal suggests an average 4.3% increase in Medicare Advantage plan payments. If the plan is adopted, it could lead to an additional $21 billion in payments for 2026 compared to the expected 2025 figures.
This follows concerns from health insurers that current rates are too low to cover medical expenses. 
"While rates in recent years have been considered insufficient" by Medicare insurers, "there is some optimism that rates could improve under a Trump CMS," said JPMorgan analyst Lisa Gill told Bloomberg.
Health insurance companies offering Medicare Advantage plans receive direct payments from the federal government to cover beneficiaries. An increase in these payments could drive higher revenue and improved margins, likely boosting investor confidence in these companies.
Notably, CVS, Humana and UnitedHealth sold more than half of the Medicare Advantage plans in 2024, as reported by KFF. Additionally, the Medicare Payment Advisory Commission noted that Medicare Advantage covered more than half of Medicare beneficiaries in 2023.
The U.S. is expected to spend $9.2 trillion over the next decade on payments to private Medicare plans.
See Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42953757/whats-going-on-with-trump-media-technology-group-stock-4">What&#8217;s Going On With Trump Media &amp; Technology Group Stock?</a>
Price Action: At the time of publication, CVS stock is trading 7.43% higher at $51.56, Humana shares are trading 7.38% higher at $289.98 and UnitedHealth stock is moving 4.37% higher at $543.48, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

Movers

What's Going On With CVS, Humana and UnitedHealth Shares Monday?

Instacart parent company Maplebear Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CART#NASDAQ">CART</a>) received an upgrade to Buy while also getting added to Needham&#8217;s conviction list on Monday as analysts expressed <a href="https://www.benzinga.com/25/01/42880309/instacart-grows-stronger-sp-midcap-400-inclusion-and-ulta-partnership-boosts-stock">concern over increasing competition</a>.
What Happened: Needham analyst Bernie McTernan upgraded Maplebear from a <a href="https://www.benzinga.com/analyst-stock-ratings">Hold rating</a> to a Buy rating. He also set a price target of $56, suggesting a nearly 30% upside from current levels.
&#8220;We think the stronger than expected results in &#8217;24E suggest our fears over competition and TAM pull forward are overblown likely driven by CART&#8217;s leading customer experience in grocery, which they continue to improve,&#8221; the Needham analyst said in a new note to clients.
Maplebear last reported quarterly earnings in November, turning in its fourth straight quarter of positive GAAP net income. Revenue jumped 12% year-over-year as orders jumped 10%. The San Francisco-based company guided for continued growth between 8% and 10%.
Check This Out: <a href="https://www.benzinga.com/news/retail-sales/25/01/42952591/thc-infused-drinks-gummies-candy-via-doordash">THC-Infused Drinks, Gummies, Candy Coming Soon To Your Front Porch Via DoorDash</a>
The Needham analyst believes Maplebear&#8217;s <a href="https://www.google.com/url?sa=t&amp;source=web&amp;rct=j&amp;opi=89978449&amp;url=https://www.benzinga.com/news/earnings/24/11/41938001/why-is-instacart-parent-maplebear-stock-sliding-today&amp;ved=2ahUKEwi7uMSxr_OKAxVD8MkDHawDPFsQFnoECBoQAQ&amp;usg=AOvVaw0w8E5Rohhvl2okt8D4GZhH">recent results</a> show stronger-than-expected customer behavior. This creates the potential for double-digit growth in the firm&#8217;s bull case. Needham put a bull case price target of $80 on Maplebear shares.
&#8220;Growth expectations for &#8217;24 have been on the rise during the second half of the year, providing further evidence to us that COVID cohorts are stable and post-COVID cohorts are large enough to drive consolidated GTV growth,&#8221; the analyst said.
McTernan noted that there&#8217;s a lot of competition in the grocery delivery space.
Maplebear stands out among consumers given its leading customer experience, McTernan says. His grocery tracking research suggests that the company maintains its supply lead versus competitors like DoorDash Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>) and Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>).
Investors have some downside protection because of potential M&amp;A opportunities in the space. Uber is looking to diversify revenue streams away from mobility. Therefore, Maplebear could be an enticing acquisition, McTernan says.
&#8220;However, given the recent price movements, we think the math is difficult to get to work, which is why we view M&amp;A as floor support,&#8221; the analyst said.
&#8220;While we are not the first to write about the potential for M&amp;A between Uber and [Instacart], we do see the structural logic, and it makes more sense now if Uber mobility fears are founded on autonomous vehicles,&#8221; he added.
Price Action: <a href="http://benzinga.com/quote/cart">Maplebear shares</a> are up approximately 90% over the past year. The stock was down 0.43% at $44.04 at the time of writing Monday, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42954168/investors-bet-big-on-alphabet-uber-genai-in-2025-what-jpmorgan-survey-reveals">Investors Bet Big On Alphabet, Uber, GenAI In 2025: What JPMorgan Survey Reveals</a></li>
</ul>
Photo: Shutterstock

CART

DASH

UBER

Instacart, Uber Deal 'Makes More Sense Now,' Analyst Says: Here's Why

AirSculpt Technologies (AIRS) appointed Yogi Jashnani as CEO and a member of the board. He succeeds Dennis Dean, Interim CEO and CFO who will conti...

AirSculpt Technologies appoints Yogi Jashnani as CEO

An announcement from Airsculpt Technologies, Inc. ( ($AIRS) ) is now available. AirSculpt Technologies has announced the appointment of Yogesh Jash...

Airsculpt Technologies Appoints Yogesh Jashnani as CEO

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Viatris (VTRS – Research Report) and Airsculpt Tec...

Analysts Offer Insights on Healthcare Companies: Viatris (VTRS) and Airsculpt Technologies, Inc. (AIRS)

Airsculpt Technologies, Inc. ( ($AIRS) ) has provided an update. Airsculpt Technologies, Inc. has announced amendments to the employment agreement ...

Airsculpt Technologies Updates Executive Compensation and Leadership

Piper Sandler lowered the firm's price target on AirSculpt Technologies (AIRS) to $6 from $7 and keeps a Neutral rating on the shares. Heading into...

AirSculpt Technologies price target lowered to $6 from $7 at Piper Sandler

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Airsculpt Technologies, Inc. (AIRS – Research Report),...

Piper Sandler Sticks to Their Hold Rating for Airsculpt Technologies, Inc. (AIRS)

FY24 consensus $185.75M. Cuts FY24 adjusted EBITDA view to $20.5M from $23M-$28M. "Last week marked my official start as CEO of AirSculpt and I am ...

AirSculpt Technologies cuts FY24 revenue view to $180M from $183M-$189M

09:41 EST Airsculpt Technologies (AIRS) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking f...

Airsculpt Technologies Inc trading resumes

09:31 EST Airsculpt Technologies (AIRS) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time,...

Airsculpt Technologies Inc trading halted, volatility trading pause

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: Johnson & Johnson (JNJ) agreed to acqu...

J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz

AAPL

AIRS

ATEC

BIIB

CRZBY

CWAN

ESTA

ICHR

INTC

ITCI

MCHP

MRVL

OPCH

RZLV

SAGE

VTRS

Press Releases

AirSculpt Technologies, Inc. (AIRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

Legal

AirSculpt® Technologies, Inc. Adds New Center In Deerfield, IL To Meet Chicago Market Demand

AirSculpt® Technologies, Inc. Announces Opening of Its New Center in Birmingham, MI

AirSculpt Technologies Announces Preliminary Third Quarter 2024 Revenue Results

Earnings

AirSculpt Technologies Reports Third Quarter Fiscal 2024 Results

AirSculpt® Technologies, Inc. Announces Opening of Its New White Plains, NY Center

Management

AirSculpt Technologies Names Yogi Jashnani Chief Executive Officer

AirSculpt Technologies Announces Participation in the ICR Conference 2025

AirSculpt Technologies Updates Fiscal Year 2024 Guidance in Advance of its Participation in the ICR Conference 2025

Accolade

Aveanna Healthcare Holdings Inc. - Common Stock

Aveanna Healthcare Hldgs

Biodesix

Cryo-Cell International, Inc. Common Stock

Cryo-Cell International

Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)

Concord Medical Services

Cross Country Healthcare, Inc. - Common Stock

Cross Country Healthcare

Castle Biosciences

DocGo

Enhabit

Enzo Biochem, Inc. Common Stock ($0.01 Par Value)

Enzo Biochem

Euda Health Holdings Limited - Ordinary Shares

EUDA Health Holdings

Fulgent Genetics

InnovAge Holding

23andMe Holding

ModivCare

National Research Corporation - Common Stock

National Research

Nutex Health

Performant Healthcare, Inc. - Common Stock

Performant Healthcare

P3 Health Partners Inc. - Class A Common Stock

P3 Health Partners

Pennant Gr

Prenetics Global Limited - Class A Ordinary Share

Prenetics Global

SBC Medical Group Holdings Incorporated - Common Stock

SBC Medical Group Holding

SHL Telemedicine Ltd - American Depositary Shares

Comments

AirSculpt Technologies

Interés en corto

AirSculpt Technologies (NASDAQ:AIRS) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL